Comment submitted by John Whysner, Associate Clinical Professor, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University
Posted : 08/09/2011     ID ：EPA-HQ-ORD-2009-0204-0005     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Dan Benishek, Memeber of Congress, Michigan's First District, House of Representatives, Congress of the United States
Posted : 08/10/2011     ID ：EPA-HQ-ORD-2009-0204-0006     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Christopher R. Kirman, Summit Toxicology LLP
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0007     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Christopher R. Kirman, Summit Toxicology LLP
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0008     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by J. Morel Symons PhD, DuPont Epidemiology Program, DuPont
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0009     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Christopher R. Kirman, Summit Toxicology LLP
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0010     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by D. E. Strother
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0011     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Gary M. Williams, Professor of Pathology, New York Medical College
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0012     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by P. Cole
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0013     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by J. J. Collins, PhD
Posted : 08/12/2011     ID ：EPA-HQ-ORD-2009-0204-0014     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by J. J. Collins, PhD
Posted : 08/15/2011     ID ：EPA-HQ-ORD-2009-0204-0015     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Anonymous public comment
Posted : 08/15/2011     ID ：EPA-HQ-ORD-2009-0204-0016     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Anonymous public comment
Posted : 08/15/2011     ID ：EPA-HQ-ORD-2009-0204-0017     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Christopher R. Kirman, Summit Toxicology LLP
Posted : 08/15/2011     ID ：EPA-HQ-ORD-2009-0204-0018     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by S. Berent, PhD
Posted : 08/15/2011     ID ：EPA-HQ-ORD-2009-0204-0019     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Michael Dourson, Toxicology Excellence for Risk Assessment (TERA)
Posted : 08/24/2011     ID ：EPA-HQ-ORD-2009-0204-0020     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Robert J. Fensterheim, Executive Director, The AN Group
Posted : 09/12/2011     ID ：EPA-HQ-ORD-2009-0204-0022     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Gary M. Marsh, Ph.D., Professor of Biostatistics, University of Pittsburgh
Posted : 09/28/2011     ID ：EPA-HQ-ORD-2009-0204-0023     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by Robert J. Fensterheim, Executive Director, Acrylonitrile Group Inc. (AN Group)
Posted : 09/29/2011     ID ：EPA-HQ-ORD-2009-0204-0024     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Comment submitted by J. Morel Symons PhD, and Sarah E. Starks, PhD, DuPont Epidemiology Program, DuPont
Posted : 09/30/2011     ID ：EPA-HQ-ORD-2009-0204-0025     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET

Late comment submitted by Robert J. Fensterheim, Executive Director, The AN Group
Posted : 12/08/2011     ID ：EPA-HQ-ORD-2009-0204-0026     Agency : EPA

Comment Period Closed
Sep 28,2011 11:59 PM ET